NewsRx

Search our medical news database

Acrongenomics Inc.

Acrongenomics Inc. Appoints De Facto Communications to Provide Public & Investor Relations Services

Published in Healthcare Mergers, Acquisitions and Ventures Week, January 19th, 2008

Acrongenomics Inc. (OTCBB:AGNM) announces that it has appointed London based De Facto Communications to manage its public and investor relations from January 2008. De Facto's appointment is a key part of the strategy to finalise the development and commercialisation of the point-of-care diagnostic device that the Company is in the process of fully acquiring. De Facto's role will be to continue to build the reputation of Acrongenomics with all stakeholders in Europe and North America as the Company completes its acquisition of Molecular Vision Limited and moves towards earning its first revenues.

In November 2007, Acrongenomics Inc. announced that they had signed a...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook